Takeda Pharmaceutical Co Stock Performance

TAK Stock  USD 18.66  0.12  0.65%   
On a scale of 0 to 100, Takeda Pharmaceutical holds a performance score of 30. The entity has a beta of 0.26, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Takeda Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Takeda Pharmaceutical is expected to be smaller as well. Please check Takeda Pharmaceutical's maximum drawdown, accumulation distribution, relative strength index, as well as the relationship between the semi variance and day typical price , to make a quick decision on whether Takeda Pharmaceutical's existing price patterns will revert.

Risk-Adjusted Performance

High

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Takeda Pharmaceutical Co are ranked lower than 30 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, Takeda Pharmaceutical disclosed solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

Five Day Return
2.3
Year To Date Return
19.46
Ten Year Return
(22.73)
All Time Return
(31.77)
Forward Dividend Yield
0.0354
Payout Ratio
0.0044
Forward Dividend Rate
0.66
Dividend Date
2025-12-11
Ex Dividend Date
2025-09-30
 
Takeda Pharmaceutical dividend paid on 11th of December 2025
12/11/2025
1
KROS Stock Surges 85.6 percent in a Year More Upside Potential in 2026
01/15/2026
2
Takeda Pharmaceutical Updates FY 2025 Earnings Guidance
01/30/2026
3
Takeda Q2 2025 Earnings Call Transcript
02/05/2026
4
Takeda deepens AI drug discovery push with 1.7 billion Iambic deal
02/09/2026
5
U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takedas Oveporexton as a Potential First-in-Class Therapy for Narc...
02/10/2026
6
Middle-class Americans are selling their plasma to make ends meet
02/12/2026
7
How FDA Priority Review For Narcolepsy Drug Oveporexton At Takeda Pharmaceutical Has Changed Its Investment Story
02/18/2026
8
Positive Phase 3 Data Demonstrate Potential for ENTYVIO to Address Treatment Gap for Children and Adolescents with Moderate to Severe Ulcerative Colitis
02/19/2026
Begin Period Cash Flow457.8 B
Total Cashflows From Investing Activities-367.1 B

Takeda Pharmaceutical Relative Risk vs. Return Landscape

If you would invest  1,450  in Takeda Pharmaceutical Co on November 25, 2025 and sell it today you would earn a total of  416.00  from holding Takeda Pharmaceutical Co or generate 28.69% return on investment over 90 days. Takeda Pharmaceutical Co is generating 0.4274% of daily returns assuming volatility of 1.1254% on return distribution over 90 days investment horizon. In other words, 10% of stocks are less volatile than Takeda, and above 92% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon Takeda Pharmaceutical is expected to generate 1.55 times more return on investment than the market. However, the company is 1.55 times more volatile than its market benchmark. It trades about 0.38 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.

Takeda Pharmaceutical Target Price Odds to finish over Current Price

The tendency of Takeda Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 18.66 90 days 18.66 
roughly 2.8
Based on a normal probability distribution, the odds of Takeda Pharmaceutical to move above the current price in 90 days from now is roughly 2.8 (This Takeda Pharmaceutical Co probability density function shows the probability of Takeda Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon Takeda Pharmaceutical has a beta of 0.26. This usually implies as returns on the market go up, Takeda Pharmaceutical average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Takeda Pharmaceutical Co will be expected to be much smaller as well. Additionally Takeda Pharmaceutical Co has an alpha of 0.3831, implying that it can generate a 0.38 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Takeda Pharmaceutical Price Density   
       Price  

Predictive Modules for Takeda Pharmaceutical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Takeda Pharmaceutical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
17.5618.6919.82
Details
Intrinsic
Valuation
LowRealHigh
17.0918.2219.35
Details
Naive
Forecast
LowNextHigh
17.4918.6219.75
Details
4 Analysts
Consensus
LowTargetHigh
17.2018.9020.97
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Takeda Pharmaceutical. Your research has to be compared to or analyzed against Takeda Pharmaceutical's peers to derive any actionable benefits. When done correctly, Takeda Pharmaceutical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Takeda Pharmaceutical.

Takeda Pharmaceutical Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Takeda Pharmaceutical is not an exception. The market had few large corrections towards the Takeda Pharmaceutical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Takeda Pharmaceutical Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Takeda Pharmaceutical within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.38
β
Beta against Dow Jones0.26
σ
Overall volatility
1.46
Ir
Information ratio 0.29

Takeda Pharmaceutical Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Takeda Pharmaceutical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Takeda Pharmaceutical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Takeda Pharmaceutical Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Takeda Stock often depends not only on the future outlook of the current and potential Takeda Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Takeda Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding3.2 B
Cash And Short Term Investments405.6 B

Takeda Pharmaceutical Fundamentals Growth

Takeda Stock prices reflect investors' perceptions of the future prospects and financial health of Takeda Pharmaceutical, and Takeda Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Takeda Stock performance.

About Takeda Pharmaceutical Performance

By examining Takeda Pharmaceutical's fundamental ratios, stakeholders can obtain critical insights into Takeda Pharmaceutical's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Takeda Pharmaceutical is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 188.07  130.94 
Return On Tangible Assets 0.02  0.02 
Return On Capital Employed 0.06  0.11 
Return On Assets 0.01  0.01 
Return On Equity 0.02  0.02 

Things to note about Takeda Pharmaceutical performance evaluation

Checking the ongoing alerts about Takeda Pharmaceutical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Takeda Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Evaluating Takeda Pharmaceutical's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Takeda Pharmaceutical's stock performance include:
  • Analyzing Takeda Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Takeda Pharmaceutical's stock is overvalued or undervalued compared to its peers.
  • Examining Takeda Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Takeda Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Takeda Pharmaceutical's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Takeda Pharmaceutical's stock. These opinions can provide insight into Takeda Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Takeda Pharmaceutical's stock performance is not an exact science, and many factors can impact Takeda Pharmaceutical's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Takeda Pharmaceutical is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Takeda Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Takeda Pharmaceutical Co Stock. Highlighted below are key reports to facilitate an investment decision about Takeda Pharmaceutical Co Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Takeda Pharmaceutical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Takeda Pharmaceutical. If investors know Takeda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Takeda Pharmaceutical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
3.302
Dividend Share
198
Earnings Share
0.23
Revenue Per Share
1.4 K
Quarterly Revenue Growth
0.042
The market value of Takeda Pharmaceutical is measured differently than its book value, which is the value of Takeda that is recorded on the company's balance sheet. Investors also form their own opinion of Takeda Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Takeda Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Takeda Pharmaceutical's market value can be influenced by many factors that don't directly affect Takeda Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Takeda Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Takeda Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Takeda Pharmaceutical's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.